These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32909849)

  • 1. Synthesis of PEGylated nanographene oxide as a nanocarrier for docetaxel drugs and anticancer activity on prostate cancer cell lines.
    Tas A; Keklikcioglu Cakmak N
    Hum Exp Toxicol; 2021 Jan; 40(1):172-182. PubMed ID: 32909849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells.
    Thapa RK; Youn YS; Jeong JH; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2016 Jul; 143():271-277. PubMed ID: 27022866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer.
    Chen Y; Xu Z; Lu T; Luo J; Xue H
    Drug Deliv; 2022 Dec; 29(1):2705-2712. PubMed ID: 35980107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer.
    Shitole AA; Sharma N; Giram P; Khandwekar A; Baruah M; Garnaik B; Koratkar S
    Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111035. PubMed ID: 32994029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel.
    Xu H; Fan M; Elhissi AM; Zhang Z; Wan KW; Ahmed W; Phoenix DA; Sun X
    Nanomedicine (Lond); 2015; 10(8):1247-62. PubMed ID: 25955123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.
    Nasrollahi F; Varshosaz J; Khodadadi AA; Lim S; Jahanian-Najafabadi A
    ACS Appl Mater Interfaces; 2016 Jun; 8(21):13282-93. PubMed ID: 27158834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer.
    Thambiraj S; Vijayalakshmi R; Ravi Shankaran D
    Sci Rep; 2021 Feb; 11(1):2808. PubMed ID: 33531521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
    Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
    Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line.
    Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells.
    Eloy JO; Ruiz A; de Lima FT; Petrilli R; Raspantini G; Nogueira KAB; Santos E; de Oliveira CS; Borges JC; Marchetti JM; Al-Jamal WT; Chorilli M
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111185. PubMed ID: 32574928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
    Liu D; Wang L; Liu Z; Zhang C; Zhang N
    J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Sadeghian-Rizi S
    Anticancer Agents Med Chem; 2018; 18(14):2017-2031. PubMed ID: 30205803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
    Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
    Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel intracellular pH-responsive formulation for FTY720 based on PEGylated graphene oxide nano-sheets.
    Masoudipour E; Kashanian S; Maleki N; Karamyan A; Omidfar K
    Drug Dev Ind Pharm; 2018 Jan; 44(1):99-108. PubMed ID: 28956455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
    Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
    Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery.
    Su M; Xie J; Zeng Q; Shu M; Liu J; Jiang Z
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111125. PubMed ID: 32600724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
    Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
    Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel gold complex nanoflowers: A chemo-biological evaluation for their use as nanotherapeutics.
    Haddada MB; Movia D; Prina-Mello A; Spadavecchia J
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111172. PubMed ID: 32534368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of PEGylated graphene oxide on lymphoma cells.
    Du L; Wu S; Li Y; Zhao X; Ju X; Wang Y
    Biomed Mater Eng; 2014; 24(6):2135-41. PubMed ID: 25226911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.